Compare FEAM & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FEAM | BTMD |
|---|---|---|
| Founded | 2016 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 80.6M | 80.4M |
| IPO Year | N/A | N/A |
| Metric | FEAM | BTMD |
|---|---|---|
| Price | $3.13 | $2.15 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $8.13 | $6.00 |
| AVG Volume (30 Days) | 96.0K | ★ 176.7K |
| Earning Date | 02-12-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 270.48 |
| EPS | N/A | ★ 0.78 |
| Revenue | N/A | ★ $195,645,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $500.00 | $2.80 |
| P/E Ratio | ★ N/A | $2.77 |
| Revenue Growth | N/A | ★ 1.34 |
| 52 Week Low | $2.82 | $2.09 |
| 52 Week High | $10.93 | $5.93 |
| Indicator | FEAM | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 38.18 | 30.41 |
| Support Level | $3.54 | $2.09 |
| Resistance Level | $3.85 | $2.42 |
| Average True Range (ATR) | 0.39 | 0.13 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 3.16 | 9.40 |
5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.